How We Can Slow Human Aging—And Why We Haven't Yet

About the episode

In this episode, Dr. Richard Miller, a pioneer in aging science, guides us through the latest research on the tools and medications that show the most promise in extending lifespan. The discussion explores the complexities of the aging process, unraveling the impacts of stress, nutrients, and hormones, and highlighting the effects of caloric restriction and targeted genetic interventions. Dr. Miller explains the potential of compounds like rapamycin, canagliflozin, and meclizine and of leveraging genetic diversity for more accurate findings while taking us through the challenges of translating this research into human treatments. He also emphasizes the significance of collaborative efforts such as the National Institute on Aging's Interventions Testing Program in advancing the field of longevity medicine and potentially developing accessible anti-aging interventions.

About the series

Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.

Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.